Bio Filter Option
Morgan Lewis
Bernard Lui

Bernard Lui

Partner

bernard.lui@morganlewis.com

Singapore Phone +65.6389.3092 Fax +65.6389.3099

10 Collyer Quay//#27-00 Ocean Financial Centre//Singapore 049315

Bernard is a partner at Morgan, Lewis & Bockius LLP and also a director at Morgan Lewis Stamford LLC, a Singapore law corporation affiliated with Morgan, Lewis & Bockius.

Bernard Lui focuses on mergers and acquisitions (M&A) and corporate finance, including initial public offerings (IPO) and placements, as well as post-IPO corporate governance and compliance issues. A registered professional with the Singapore Exchange (SGX), he also supervises companies listed on the Catalist (the sponsor-supervised board of the SGX). Bernard currently serves as the leader of the firm’s Singapore corporate and business transactions practice.

With 30 years of experience, Bernard has managed a number of significant M&A and corporate finance transactions across a broad spectrum of sectors. In line with these transactions, he has developed a strong reputation as a deal-maker who can deliver clients’ objectives in an innovative style regardless of complexitíes. His deal work has been recognized by Chambers Global and Chambers Asia-Pacific, The Legal 500 Asia Pacific, IFLR1000, and Asialaw Leading Lawyers. Chambers Asia Pacific (2019) said that Bernard is appreciated by clients for his “good awareness of the key drivers from the commercial perspective and providing clear advice.” The Legal 500 described him as a “quick-thinking” and “outstanding industry expert” who has a “very keen grasp of commercial drivers backed by solid technical legal knowledge.”

Bernard is a member of the Singapore Institute of Directors’ Professional Development Committee and Regulatory Affairs Committees.

Awards and Affiliations

Recognized, Capital Markets Law, The Best Lawyers in Singapore (2022) 

Highly Regarded, IFLR1000 Financial and Corporate (2018–2022) 

Leading Individual, Capital Markets: Equity and Debt: Local Firms, Singapore, The Legal 500 Asia Pacific (2020–2023)

Leading Individual, Capital Markets: Local Firms, Singapore, The Legal 500 Asia Pacific (2019)

Recommended, Corporate and M&A: Local Firms, Singapore, The Legal 500 Asia Pacific (2020, 2021)

Recommended, Restructuring and Insolvency: Local Firms, Singapore, The Legal 500 Asia Pacific (2020, 2021)

Recommended, Capital Markets: Local Firms; Shipping: Local Firms, Singapore, The Legal 500 Asia Pacific (2018)

Ranked, Capital Markets: Domestic, Singapore, Chambers Global (2012–2022)

Ranked, Capital Markets: Domestic, Singapore, Chambers Asia-Pacific (2012–2023)

Admissions

  • Advocate & Solicitor, Supreme Court of Singapore

Education

  • National University of Singapore, 1991, LLB, Hons

Sectors

  • Healthcare

Services

  • Corporate, Finance & Investment Management
  • Capital Markets & Public Companies
  • Healthcare Transactions
  • Shareholder Activism Defense

Regions

  • Asia Pacific
  • Southeast Asia
  • India

Events

4/25/2017 - Morgan Lewis Public Company Academy

News

1/13/2023 - Morgan Lewis Earns New Rankings in 2023 Legal 500 Asia-Pacific Guide
12/15/2022 - Morgan Lewis Earns New Rankings in 2023 Chambers Asia-Pacific Guide
1/26/2022 - Morgan Lewis Advising Huayou in Acquisition of Lithium Mine in Zimbabwe
12/16/2020 - Morgan Lewis Earns High Rankings in 2021 Chambers Asia-Pacific Guide
1/30/2020 - Morgan Lewis Stamford Advises CITIC Envirotech on Voluntary Delisting
12/10/2019 - Morgan Lewis Earns High Rankings in 2020 Edition of Chambers Asia-Pacific
12/2/2019 - Morgan Lewis Advises CITIC on Voluntary Delisting and Exit Offer
6/20/2019 - Morgan Lewis Advises on Singapore Listing of Revez Corporation Ltd
2/7/2017 - Morgan Lewis Featured in China Business Law Journal’s 2016 Deal of the Year Report
2/24/2016 - Corporate Counsel Recognize Morgan Lewis in Chambers Asia-Pacific 2016 Edition

Publications

11/2/2022 - SGX RegCo Proposes Independent Director Tenure Limits, Director and CEO Pay Disclosure
9/20/2022 - Data Protection Trends in Asian Healthcare & Hospitals, Healthcare Digital
8/18/2022 - The Shareholder Rights and Activism Review: Singapore, The Law Reviews
8/2/2022 - Singapore Personal Data Protection Act Changes Have Implications for Healthcare Sector
7/25/2022 - China’s Data Privacy Laws and Implications for Healthcare Industry
6/1/2022 - Shareholder Activism in Singapore: Overview, Thomson Reuters Practical Law
5/1/2022 - Shareholders' Rights in Private and Public Companies in Singapore: Overview, Thomson Reuters Practical Law
9/7/2021 - Rolling Out SPAC Listings in Singapore
8/24/2021 - Navigating Asia-Pacific Health M&A in the Wake of COVID, Law360
8/23/2021 - The Shareholder Rights and Activism Review: Singapore, The Law Reviews
8/17/2021 - Global Healthcare Transactions Series: Check Out Our Asia-Pacific Edition
8/16/2021 - Global Healthcare Series: How COVID-19 Impacted Healthcare Transactions in the Asia Pacific
4/9/2021 - Singapore Is Looking to Bring In SPACS
8/25/2020 - Tele-Tuesday: Singapore’s Telehealth Expansion
June 25, 2020 (Updated August 13, 2020) - Telehealth Use Surges Around the World Amid COVID-19
7/21/2020 - COVID-19 Brings Surge in Telehealth Use Around the World
7/17/2020 - Singapore’s Telehealth Expansion: Considerations for Providers
5/31/2019 - Singapore Grants First Domestic DIP Financing Application Based on US Law
11/20/2018 - Singapore Proposes New Delisting Rules to Protect Minority Interests
3/13/2018 - Singapore Joint Investigations Arrangement to Cover More Financial, Regulatory Offences
4/3/2017 - Singapore Exchange Amends Listing Rules Following Changes to the Companies Act
7/20/2016 - SGX to Set Up Subsidiary Company ‘Regco’ for Regulatory Functions